Using fiducial-marker-based robotic respiratory tumor tracking. we treated perihilar cholangiocarcinoma patients in the STRONG trial with 15 daily fractions of 4 Gy. For each of the included patients. in-room diagnostic-quality repeat CTs (rCT) were acquired pre- and post-dose delivery in 6 treatment fractions to analyze inter- and intrafraction dose variations. https://pipingrockers.shop/product-category/ojibwa-esiak/